Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Relay Therapeutics Inc (NASDAQ: RLAY) closed the day trading at $6.41 up 1.75% from the previous closing price of $6.30. In other words, the price has increased by $1.75 from its previous closing price. On the day, 1.19 million shares were traded. RLAY stock price reached its highest trading level at $6.58 during the session, while it also had its lowest trading level at $6.21.
Ratios:
For a better understanding of RLAY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.73 and its Current Ratio is at 20.73. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 20, 2023, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $12.50.
Raymond James Upgraded its Outperform to Strong Buy on April 19, 2023, while the target price for the stock was maintained at $29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 29 ’24 when Bergstrom Donald A sold 2,686 shares for $6.38 per share. The transaction valued at 17,137 led to the insider holds 527,427 shares of the business.
Catinazzo Thomas sold 1,695 shares of RLAY for $10,814 on Apr 29 ’24. The Chief Financial Officer now owns 339,803 shares after completing the transaction at $6.38 per share. On Apr 29 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,623 shares for $6.38 each. As a result, the insider received 10,355 and left with 325,767 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 850876224 and an Enterprise Value of 153572144. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.08 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 4.347 whereas that against EBITDA is -0.422.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $13.32, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -7.02%, while the 200-Day Moving Average is calculated to be -26.22%.
Shares Statistics:
Over the past 3-months, RLAY traded about 1.24M shares per day on average, while over the past 10 days, RLAY traded about 1342320 shares per day. A total of 127.46M shares are outstanding, with a floating share count of 91.19M. Insiders hold about 31.30% of the company’s shares, while institutions hold 72.51% stake in the company. Shares short for RLAY as of 1715731200 were 11885608 with a Short Ratio of 9.56, compared to 1713139200 on 10692091. Therefore, it implies a Short% of Shares Outstanding of 11885608 and a Short% of Float of 11.5.
